Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Calyx, an eClinical and Regulatory solutions and services provider announced the availability of Calyx Supply Simulation, a clinical trial supply forecasting service available through Calyx's in-house expert statistical design and trial supplies ...
read more
Thursday, February 11, 2021
Calyx announced an expansion to its Executive Leadership Team. Richard Wallace joins Calyx as Chief Digital and Information Officer (CDIO).
read more
AGC Biologics produces a GMP-grade clinical batch of CALY-002 for Calypso Biotech.
read more
SACRAMENTO, Calif. (AP) — California lawmakers on Tuesday approved a hotly contested bill that would impose one of the strictest vaccination laws in the country, after five hours of highly emotional testimony that brought hundreds of opponents to the...
read more
Rockwell Medical provided an update regarding Calcitriol, the company's FDA approved active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis.
read more
CalAmp has announced a collaboration with Cryoport to develop a next generation condition monitoring system to further assure the security of global temperature controlled pharmaceutical shipments.
read more
Caisson Biotech, a provider of half-life extension and drug delivery platforms, has established a global manufacturing partnership with CordenPharma International, a full-service Contract Development & Manufacturing Organization (CDMO) manufacturing ...
read more
Caeregen Therapeutics, a regenerative medicine therapeutics company and Wacker Biotech, a contract development and manufacturing organization (CDMO), will collaborate on the development and production of CTR-107 (Noregen™), a novel regenerative ...
read more
Wednesday, August 16, 2017
CAEK has entered into an exclusive agreement with Henry Schein Dental, a division of Henry Schein to sell its uniquely designed HIPAA software, LayerCompliance.
read more
Cadent Therapeutics today announced the receipt of the second milestone payment from Novartis following the initiation of a Phase 2 clinical study of MIJ821.
read more
Tuesday, October 17, 2017
Cadent Therapeutics has earned a milestone payment for the initiation of a Phase 1 clinical study of a subtype selective NMDA receptor negative allosteric modulator for treatment-resistant depression.
read more
C2 PHARMA, a manufacturer and supplier of ophthalmic and niche active pharmaceutical ingredients (APIs), announced the approval of a C-DMF for Digoxin, an API manufactured by their Polish manufacturing partner Nobilus Ent.
read more
Wednesday, October 19, 2022
C2 PHARMA, a pharmaceutical group focused on manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs) globally, is expanding the API product portfolio. Tropicamide API is launching with regulatory filings in both ...
read more
Wednesday, November 06, 2019
C2 PHARMA continues to build its active pharmaceutical ingredient (API) and botanical extracts product portfolio.
read more
Friday, February 26, 2021
C2 PHARMA (C2P) has expanded its portfolio of APIs and botanical extracts throughout 2020 and will continue pursuing the expansion into 2021.
read more